EP2825059A2 - Animal feed supplement and assay method - Google Patents
Animal feed supplement and assay methodInfo
- Publication number
- EP2825059A2 EP2825059A2 EP13711456.7A EP13711456A EP2825059A2 EP 2825059 A2 EP2825059 A2 EP 2825059A2 EP 13711456 A EP13711456 A EP 13711456A EP 2825059 A2 EP2825059 A2 EP 2825059A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- additive according
- malt
- animal
- animal feed
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 24
- 238000003556 assay Methods 0.000 title description 2
- 239000006052 feed supplement Substances 0.000 title 1
- 241000283073 Equus caballus Species 0.000 claims abstract description 41
- 102000004190 Enzymes Human genes 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 36
- 229940088598 enzyme Drugs 0.000 claims abstract description 36
- 239000012855 volatile organic compound Substances 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 26
- 108010065511 Amylases Proteins 0.000 claims abstract description 23
- 102000013142 Amylases Human genes 0.000 claims abstract description 23
- 235000019418 amylase Nutrition 0.000 claims abstract description 23
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims abstract description 22
- 210000003608 fece Anatomy 0.000 claims abstract description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 13
- 235000019730 animal feed additive Nutrition 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 11
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940025131 amylases Drugs 0.000 claims abstract description 7
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019260 propionic acid Nutrition 0.000 claims abstract description 7
- 208000004998 Abdominal Pain Diseases 0.000 claims abstract description 6
- 208000002881 Colic Diseases 0.000 claims abstract description 6
- 208000028774 intestinal disease Diseases 0.000 claims abstract description 6
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims abstract description 6
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108010005131 levanase Proteins 0.000 claims abstract description 6
- 238000012544 monitoring process Methods 0.000 claims abstract description 6
- 208000010444 Acidosis Diseases 0.000 claims abstract description 4
- 230000007950 acidosis Effects 0.000 claims abstract description 4
- 208000026545 acidosis disease Diseases 0.000 claims abstract description 4
- 108010089934 carbohydrase Proteins 0.000 claims abstract description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims abstract description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 34
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 16
- 235000013339 cereals Nutrition 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 14
- 230000029087 digestion Effects 0.000 claims description 14
- 244000075850 Avena orientalis Species 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 12
- 230000000996 additive effect Effects 0.000 claims description 12
- 240000005979 Hordeum vulgare Species 0.000 claims description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 7
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims description 6
- 240000004658 Medicago sativa Species 0.000 claims description 4
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000003651 drinking water Substances 0.000 claims description 3
- 235000020188 drinking water Nutrition 0.000 claims description 3
- 239000005418 vegetable material Substances 0.000 claims description 3
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 claims description 2
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 241000209761 Avena Species 0.000 abstract 1
- 241000283086 Equidae Species 0.000 description 25
- 239000004382 Amylase Substances 0.000 description 19
- 238000000824 selected ion flow tube mass spectrometry Methods 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 229920002472 Starch Polymers 0.000 description 15
- 235000019698 starch Nutrition 0.000 description 15
- 150000002500 ions Chemical class 0.000 description 14
- 239000008107 starch Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 230000009469 supplementation Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 12
- 235000014633 carbohydrates Nutrition 0.000 description 11
- 150000001720 carbohydrates Chemical class 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 241000777300 Congiopodidae Species 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000090 biomarker Substances 0.000 description 6
- 230000002478 diastatic effect Effects 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000007413 intestinal health Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000003674 animal food additive Substances 0.000 description 5
- 108010019077 beta-Amylase Proteins 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 230000035784 germination Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 238000000513 principal component analysis Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- 229920002670 Fructan Polymers 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 4
- 235000021257 carbohydrate digestion Nutrition 0.000 description 4
- BQOFWKZOCNGFEC-UHFFFAOYSA-N carene Chemical compound C1C(C)=CCC2C(C)(C)C12 BQOFWKZOCNGFEC-UHFFFAOYSA-N 0.000 description 4
- 239000012159 carrier gas Substances 0.000 description 4
- 238000003795 desorption Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000000491 multivariate analysis Methods 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 241000252983 Caecum Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001491 aromatic compounds Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004534 cecum Anatomy 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 238000005360 mashing Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 2
- XWJBRBSPAODJER-UHFFFAOYSA-N 1,7-octadiene Chemical compound C=CCCCCC=C XWJBRBSPAODJER-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- VLJXXKKOSFGPHI-UHFFFAOYSA-N 3-methylhexane Chemical compound CCCC(C)CC VLJXXKKOSFGPHI-UHFFFAOYSA-N 0.000 description 2
- CHBAWFGIXDBEBT-UHFFFAOYSA-N 4-methylheptane Chemical compound CCCC(C)CCC CHBAWFGIXDBEBT-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000007558 Avena sp Nutrition 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 2
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229930006737 car-3-ene Natural products 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical group CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- -1 linseed oil) Natural products 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- 238000007738 vacuum evaporation Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- JXPOLSKBTUYKJB-UHFFFAOYSA-N xi-2,3-Dimethylhexane Chemical compound CCCC(C)C(C)C JXPOLSKBTUYKJB-UHFFFAOYSA-N 0.000 description 2
- WGECXQBGLLYSFP-UHFFFAOYSA-N (+-)-2,3-dimethyl-pentane Natural products CCC(C)C(C)C WGECXQBGLLYSFP-UHFFFAOYSA-N 0.000 description 1
- GDDAJHJRAKOILH-QFXXITGJSA-N (2e,5e)-octa-2,5-diene Chemical compound CC\C=C\C\C=C\C GDDAJHJRAKOILH-QFXXITGJSA-N 0.000 description 1
- RJUCIROUEDJQIB-GQCTYLIASA-N (6e)-octa-1,6-diene Chemical compound C\C=C\CCCC=C RJUCIROUEDJQIB-GQCTYLIASA-N 0.000 description 1
- ULPMRIXXHGUZFA-UHFFFAOYSA-N (R)-4-Methyl-3-hexanone Natural products CCC(C)C(=O)CC ULPMRIXXHGUZFA-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- CZGAOHSMVSIJJZ-UHFFFAOYSA-N 2,4-dimethyl-1-heptene Chemical compound CCCC(C)CC(C)=C CZGAOHSMVSIJJZ-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- PFCHFHIRKBAQGU-UHFFFAOYSA-N 3-hexanone Chemical compound CCCC(=O)CC PFCHFHIRKBAQGU-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical group CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 238000006037 Brook Silaketone rearrangement reaction Methods 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 108010042889 Inulosucrase Proteins 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- STNJBCKSHOAVAJ-UHFFFAOYSA-N Methacrolein Chemical compound CC(=C)C=O STNJBCKSHOAVAJ-UHFFFAOYSA-N 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 241001606091 Neophasia menapia Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 235000019714 Triticale Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OFLXLNCGODUUOT-UHFFFAOYSA-N acetohydrazide Chemical compound C\C(O)=N\N OFLXLNCGODUUOT-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000015107 ale Nutrition 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000021024 carbohydrate-rich diet Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000021310 complex sugar Nutrition 0.000 description 1
- 229940124301 concurrent medication Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000002790 cross-validation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- POCFBDFTJMJWLG-UHFFFAOYSA-N dihydrosinapic acid methyl ester Natural products COC(=O)CCC1=CC(OC)=C(O)C(OC)=C1 POCFBDFTJMJWLG-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- PLZDDPSCZHRBOY-UHFFFAOYSA-N inaktives 3-Methyl-nonan Natural products CCCCCCC(C)CC PLZDDPSCZHRBOY-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000015095 lager Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004890 malting Methods 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010202 multivariate logistic regression analysis Methods 0.000 description 1
- BAPROVDXKNPHAM-UHFFFAOYSA-N n-(2-aminoethyl)-3-(3,5-ditert-butyl-4-hydroxyphenyl)propanamide Chemical compound CC(C)(C)C1=CC(CCC(=O)NCCN)=CC(C(C)(C)C)=C1O BAPROVDXKNPHAM-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000004458 spent grain Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 108010022290 sucrose - fructan 6-fructosyltransferase Proteins 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000007473 univariate analysis Methods 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 241000228158 x Triticosecale Species 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01002—Beta-amylase (3.2.1.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0004—Gaseous mixtures, e.g. polluted air
Definitions
- the invention relates to dietary supplements and to methods of testing the intestinal health of animals including equine animals
- the dietary supplements comprise a plurality of enzyme and typically include malts, such as high diastatic power (DP)malts.
- malts such as high diastatic power (DP)malts.
- Intestinal disease is the biggest cause of mortality and a major cause of morbidity and economic loss in horses. There is a need to be able to identify the health of the intestine of the horse and to improve digestion of food by the horse.
- the horse has a digestive strategy that is heavily reliant upon hindgut fermentation of dietary fibre.
- C. Janis, Evolution, 1976, 30, 757-774 A consortium of intestinal bacteria in the caecum and colon hydrolyse dietary fibre, releasing soluble carbohydrates which are fermented to short chain fatty acids (acetic, propionic and butyric acid), which provide horses with the majority of their energy requirements.
- E.N. Bergman, Physiol. Rev., 1992, 70, 567- 590 The energy requirements of horses undertaking heavy work or those performing as athletes far exceed energy arising from hindgut fermentation alone. This "energy gap" is filled by supplementing the diet with readily hydrolysable (digestible) carbohydrate, commonly in the form of grain.
- Acute intestinal disease (“colic") is the single most important cause of mortality in horses and a significant cause of morbidity and economic loss in managed horse populations.
- Evidence is also emerging of the importance of intestinal disease as a cause of reduced productivity in the 100 million working horses globally.
- M.M. Curran et al Prop Anim Health Prod. 2005, 37, 47-65.
- the faecal metabolome reports specifically on the metabolic interplay between host, diet and intestinal microbiota and offers the potential to identify biomarkers which can act as proxy for specific bacterial populations.
- D.M. Jacobs et al NMR Biomed. , 2008 21, 615-626)
- P.J. Turnbaugh et al Cell, 2008, 134, 708-713.
- VOCs Volatile organic compounds
- the inventors realised that digestion might be improved by providing several different enzymes at once, to improve breakdown of plant-based products. Moreover, there was a need to be able to provide the enzymes in a cost effective form to allow the bulk supply of the enzymes as a feedstuff.
- Malt is germinated seeds or grain.
- the seeds are made to germinate by soaking in water and are then usually halted by drying with hot air.
- Germination causes the seed to produce a variety of enzymes that modify, for example, starches into sugars, through the production of amylases and other carbohydrases, such as fructanases.
- the germination process also induces other enzymes, such as proteases that break down proteins in the grain.
- Conventionally malted grains used in the production of beer, whisky, malted vinegar or malt flavourings are kiln dried at temperatures up to 90°C for ales, 80°C for lagers and lower for malts required to be high in enzyme content. At higher temperatures greater proportions of the enzymes present in the malt are denatured by the heating and drying process.
- barley grains are typically grown in a current of cool humidified air and are allowed to germinate ('sprout'). They are then carefully dried ('kilned')and cleaned and the rootlets removed. The sprouted grains are then milled and water is added at the appropriate temperature to make a mash.
- the various enzymes present are effective at different temperatures, Therefore the mash is usually started at around 50°C when proteases and beta amylases break down the ground malt. The mash temperature is progressively raised to 65°C when the starch gelatinises and permits degradation to sugars by the action of alpha amylases. After mashing and stirring for around 1 hour the liquid is separated from the residual solids ('spent grain').
- malt extract typically 80% solids in solution.
- Malt extract may be made without active enzymes or as an enzyme-rich extract depending on the temperatures used in evaporation.
- Enzyme-rich extracts have high diastatic power (high DP) and the nature of the enzymes is regulated by the nature of the seed, such as barley variety being malted, the growth conditions during germination and by gentler kilning programmes. The details of the kilning and drying of the malt and of the concentration of the wort determine the colour and flavour of the malt extract and the activity of the enzymes contained in it.
- the final malt extract is a sugar-rich solution which may, depending on the process used, contain soluble carbohydrate, peptides, amino acids and a range of enzymes.
- a high DP extract is used for starch degrading activity and enzymes present typically include amylytic activity with a-amylase, ⁇ -amylase, debranching enzymes, a-glucosidase, transglucosylases, and phosphorylases.
- the extract will also typically have significant levels of peptidases and other proteolytic enzymes.
- Fructosyltransferase enzymes are found in grasses and in cereals including barley (Altenbach et al 2005 FEBS Letters 579 (21) 4647-4653) and as well as being involved in fructan synthesis, have glycoside hydrolase activity to degrade fructans to less complex sugars. Barley leaves contain sucrose-fructan 6-fructosyltransferase which may also be found in malt extract.
- green malt Prior to heating and drying the malt is called “green malt”. This is where the grain has germinated but not yet been dried. Typically, for example, seed is immersed or steeped in water two or three times over a period of two or three days to allow the seeds to absorb moisture and start to germinate. The seeds are usually allowed to sprout and occasionally turned for a period of several, typically 3-6 days. At this stage it is called “green malt”. After this stage it would normally be dried for conventional use.
- malted grains allow the production of a ready source of enzymes that might assist in the digestion of foodstuffs in animals.
- the invention provides an animal feed additive comprising a plurality of enzymically active enzymes. That is, the enzymes are still capable of having enzyme activity or a substrate, for example treating starch down into one or more smaller components such as mono- or di- saccharides.
- the plurality of enzymes may be carbohydrases, which are capable of breaking down one or more carbohydrates into smaller components, or proteases.
- the enzymes may be plant derived, for example derived from germinating seeds.
- the enzymes are one or more amylases and/or one or more fructanases.
- Amylases catalyse the breakdown of starch into sugars.
- a-Amylase breaks starch down. It yields maltotriose and maltose from amylose, or maltose, glucose and limit dextrin from amylopectin.
- ⁇ -Amylase breaks starch into maltose. Both a-amylase and ⁇ -amylase are found in seeds during germination. Both a- and ⁇ -amylase may be present.
- Fructanases break down fructans, which are believed to be involved in the induction of laminitis in hoofed animals.
- Fructanases include2,l-P-D-fructan hydrolases.
- the enzymes are conveniently provided by a malt or malt extract.
- Malt is typically green or high diastatic power (high dp) malt. That is from germinated seeds that have not been heated and dried above 40°C, 50°C or 55°C but below 75°C or 70°C to halt germination as this often reduces the activity of enzymes remaining after that heating step.
- malt heated and dried above that temperature may be used, but with lower enzymatic activity.
- water is added and heated to at least approximately 40°C or 50°C to form the mash.
- the temperature may be raised to 55°C, 60°C or 65°C but below 75°C or 70°C and then separated from the grain.
- the liquid wort may be evaporated by, for example, vacuum evaporation.
- a malt extract may be prepared by, for example, crushing the malt and extracting the enzymes with, for example, hot water. The extract may then be evaporated, for example to an 80% sugar solution containing the enzymes (an "amylase rich extract").
- Diastatic power is measured in °Lintner (°L) or by Windisch Kolbach Units (°WK). A malt with enough power to self-convert into starch has a diastatic power near 35° Lintner.
- a high diastatic malt typically has a value of above 35° Lintner (94° WK), or typically above 45° L, 50° L, 60° L, 70° L or above 80° L.
- Potentially any seed may be used to produce the malt.
- wheat, triticale, sorghum, maize, buck wheat or rice may be used.
- Barley is typically used as this is regularly used as a source of malt for the brewing industry in many countries. Malt is also tasty to animals such as horses so assists in administering the feed additive.
- the ability to increase utilisation of carbohydrates may also be applied to other vegetable eating animals includes ovine, bovine, other equine animals such as zebra, deer, and rabbits.
- the animal feed additive may be provided as a separate orally acceptable product, for example in combination with one or more bulking agents, stabilisers, thickeners, additional vitamins, minerals, edible oils (such as linseed oil), salts and/or electrolytes. It may be provided as a liquid, powder or moist product. It may be added to drinking water.
- the animal feed additive is provided in combination with vegetable material. This may be a part of the animal's normal feed to prevent, for example colic, or to increase the energy utilisation from the feed.
- the feed may be, for example, grains such as oats (including bruised, naked or rolled oats), barley or maize; hay such as Timothy hay, or alfalfa hay; or silage.
- a balancer such as an oat balancer, may also be provided.
- Animal feed or drinking water in combination with the animal feed additive according to the invention is provided.
- the use of the animal feed additive as in an animal feed is also provided.
- Methods of improving the digestion of food for example to improve the use of the energy provided stored within the feed is also provided, using the animal feed additives of the invention.
- Methods of preventing or treating food digestion associated conditions, such as colic, acidosis and/or laminitis is also provided by administering a food additive according to the invention.
- the animal may be ovine, bovine, equine, deer or rabbit.
- Amylase rich extracts are typically made by using hot water extraction of germinated barley and evaporation to an 80% sugar solution (D.E. Briggs, The Principles of Mashing In : Malt and brewing, Blackie, 1998).
- the amount of food additive provided will vary from animal to animal and food to food.
- racing horse have been successfully fed 1% body weight of bruised oats, naked oats and oat balancer (ratio 1 :0.5: 1 w/w. 13MJ/kg dry weight energy density), 1% body weight Timothy hay, 0.15% alfalfa hay plus linseed oil, salt and electrolyte.
- Daily intake was split between 3 feeds, the evening feed comprising 66% of each horse's daily grain intake. 200 grams of the amylase rich extract was provided. 70% of the daily dose was administered to the larger evening feed.
- VOCs Volatile Organic Compounds
- the invention provides a method of monitoring the health of the gut of an equine animal, comprising measuring the concentration of one or more volatile organic compounds from the faeces of an animal selected from acetic acid, butanoic acid, propanoic acid, 2-methyl propanoic acid and 3 -methyl butanoic acid.
- One, two, three, four or all five compounds may be measured.
- One or more of 4-methyl phenol, acetone and/or isopropyl alcohol may be measured.
- the faeces are typically fresh or fresh faeces frozen substantially afterwards.
- the amount may be compared to an amount measured prior to administration of an additive according to the invention. It may also be used to determine whether an animal should be treated with, for example, an additive of the invention.
- the invention also provides a computer implemented method for determining in a sample of faeces the concentration of one or more VOCs by the method of the invention and comparing to a predetermined normal value. This gives an indication of the relative health of the animal.
- Apparatus comprising a computer processor and a memory configured to carry out a method of the invention are also provided.
- Figure 1 A schematic diagram of the SIFT-MS instrument indicating the main components. Headspace samples of faeces in a Nalophan bag may be analysed as illustrated, by attaching the bag to the inlet capillary of the instrument.
- Figure 2 Univariate analysis of eight most abundant volatile organic compounds by GC-MS in faeces of Thoroughbred racehorses.
- Figure 3 Scores plots for multivariate analysis of faecal SIFT-MS data from racehorses pre- (labelled “na”) and post-supplementation (labelled “nb”); A) PCA model, B) OPLS-DA model. (Post-supplementation plots to the left of the centre y axis.)
- Figure 4 S-plot (A) and loadings plot with 95% confidence intervals (B) for the OPLS-DA model describing faecal VOCs in horse faces before and after supplementation with enzyme- rich malt.
- the study population comprised 8 castrated male (gelding), Tb racehorses between the ages of 4 and 6 years old. Each horse was stabled at the same premises, under the management of the same trainer and in active race training. All horses were free from concurrent medical treatment throughout the study. All horses were fed a standard diet comprising 1% bodyweight fed as a mix of bruised oats, naked oats and oat balancer (ratio of 1 :0.5 : 1 respectively, 13MJ/kg dry weight energy density), 1% bodyweight Timothy hay, 0.15% bodyweight alfalfa hay plus linseed oil, salt and electrolyte supplementation. Daily intake was divided between three feeds, the evening feed comprising 66% of each horse's daily concentrate (grain) intake.
- Frozen faecal samples were defrosted at room temperature. Five grams of each sample was removed from the bulk sample and placed inside a Nalophan sampling bag, made up of 65 mm diameter Nalophan NA tubing 25 ⁇ thick. The sample bags were 40 cm long. One end of the bag was fitted with a Swagelok connector and the other end of the bag was sealed and filled with hydrocarbon free air to generate the headspace of VOCs. The bags were then placed in an incubator at 40°C for 1 hour to allow the volatile organic compounds (VOCs) to equilibrate between headspace and solid sample.
- VOCs volatile organic compounds
- the headspace was analysed by connecting the Swagelok fitting to the capillary inlet of a selected ion flow tube mass spectrometry (SIFT-MS). 200ml of headspace was then pumped across a thermal desorption (TD) tube for thermal desorption - gas chromatography - mass spectrometry (TD-GC-MS) as described below.
- SIFT-MS selected ion flow tube mass spectrometry
- SIFT-MS is a real time trace gas analyser which can accurately quantify the concentration of trace gases present.
- the model used in this study (Mk 2) can typically detect down to a level 10 parts-per-billion (ppb).
- GC-MS on the other hand, is much slower but when combined with TD offers the ability to detect VOCs at the parts per trillion (ppt) level. As it is not a direct method of analysis, it is also less quantitative than the direct SIFT- MS method.
- SIFT-MS has been described in detail previously (A. Amann et al, Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring, World Scientific, Singapore, 2005) (D. Smith et al, Mass Spectrom. Rev., 2005, 24, 661-700) so only a brief summary is given here.
- Analysis requires the generation of precursor ions which are produced in a microwave discharge and are selected by the first of two quadrupole mass filters before being injected into a fast flowing helium carrier gas (Fig. 1). These ions then react with the VOCs in the sample which is drawn into the flow tube via a heated capillary inlet.
- the available precursor ion species are H 3 0 + , NO + and 0 2 + .
- the precursor and product ions in the carrier gas are sampled by a downstream orifice and pass into a differentially pumped second quadrupole mass spectrometer and ion counting system for analysis. Full spectra of the count rates at each m/z value in the range m/z 10 to m/z 140 were recorded for all the samples using each precursor ion.
- the identities and concentrations of various components were determined using the on-line database containing reaction rate coefficients, developed from numerous detailed selected ion flow tube (SIFT) studies of various classes of compounds (alcohols, aldehydes, ketones, hydrocarbons, etc) with the three precursor ions. (D. Smith et al, Mass Spectrom. Rev., 2005, 24, 661-700) (D. Smith et al, Rapid Comms. in Mass Spectr., 1996, 10, 1183) (P. Spanel et al nt. Rev. Phys. Chem., 1996, 15, 231-271).
- SIFT-MS data were normalised to the precursor ions for each set of spectra in order to account for the variability in ion count. These data were then exported to spread sheet software for further processing and removal of zero values. The data were then imported into SFMCA-P+ as described below.
- the Nalophan bags were connected to a TD tube for subsequent analysis by GC-MS to pre- concentrate the headspace via an automated pump using 200 ml of faecal headspace.
- Standard stainless-steel TD sorbent cartridges were used, containing dual packing comprising 50% Tenax TA and 50% Carbotrap (Markes International Limited, Llantrisant, UK). Cartridges were conditioned before use by purging with helium carrier gas for 2 min at room temperature followed by 1 hour at 320 °C.
- Captured volatiles were analysed using an AutoSystem XL gas chromatograph equipped with an ATD 400 thermal desorption system and TurboMass mass spectrometer (Perkin Elmer, Wellesley, MA). CP grade helium (BOC gases, Guildford, UK) was used as the carrier gas throughout, after passing though a combined trap for the removal of hydrocarbons, oxygen and water vapour. Cartridges were desorbed by purging for 2 min at ambient temperature then for 5 min at 300 °C. Volatiles purged from the cartridge were captured on a cold trap which was initially maintained at -30 °C.
- the trap was heated to 320 °C using the fastest available heating rate and maintained at that temperature for 5 minutes whilst the effluent was transferred to the gas chromatograph via a heated (180 °C) transfer line coupled directly to the chromatographic column.
- a Zebron ZB624 chromatographic column (dimensions 30m x 0.4mm x 0.25mm ID) was used (Phenomenex, Torrance, CA). The gas chromatograph oven was maintained at 50 °C for 4 min following injection and was then raised at 10 "C.rnin "1 to 220 °C for 9 min. Separated products were transferred by heated line to the mass spectrometer and ionised by electron bombardment. The spectrometer was set to carry out a full scan from mass/charge ratios (m/z) 33 to 350 using a scan time of 0.3s with a 0.1s scan delay. The resulting mass spectra were combined to form a total ion chromatogram (TIC) by the GCMS integral software (TuboMass ver 4.1) and resolved compounds were identified using AMDIS software and the NIST mass spectral database.
- TIC total ion chromatogram
- Table 1 lists the identity of metabolites detected by GC-MS from the faeces of our population pre- and post-supplementation.
- Figure 2 illustrates the distribution of abundance measurements for the eight most abundant compounds detected by GC-MS. For acetic, butanoic and propanoic acid, propanoic acid 2 methyl and butanoic acid 3 methyl, median abundance is significantly reduced in faeces post-supplementation compared to pre- supplementation (P ⁇ 0.05).
- a PCA model for faecal SIFT-MS data demonstrated poor model fit and very poor predictive ability, with an R 2 value of 0.37 and Q 2 value of -0.07.
- a scores plot of the first two components of this model is shown in Fig 3 A, with the 95% confidence range for Hotellings T 2 plotted as an ellipse. Although two observations lie close to this limit, they are not outside of the range and therefore were not excluded from further analysis.
- the same data were modelled using an OPLS model, a scores plot is illustrated in figure 3B.
- FIG. 4A An S-plot of loadings for the OPLS model (Fig 4A) identifies some compounds to be strongly associated with class, the significance of the association for each is explored with 95% confidence intervals in figure 4B.
- the following ions are significantly associated with class i.e. differentiate between pre- and post-supplementation faeces: m/z 33, m/z 59, m/z 69, m/z74 and m/z 95. Most likely identification of each compound is: m/z 33 : methanol; m/z 59: acetone; m/z 69 methanol (with 2 hydrates), a consequence of samples being moist (N. Richards, M. Choct, G.N. Hinch and J.B.
- VOC diversity observed in our equine samples compared to human faecal samples.
- C.E. Garner et al FASEB J, 2007, 21, 1675 - 1688.
- Garner et al. reported 297 VOC's in 151 samples.
- a further difference is that in the human study 78 VOC's were present in 50% or more of the samples from non-diseased individuals; in our equine study only 28 VOC's fulfil this criterion.
- sampling method, sample size and method of VOC analysis this observation does suggest that a more limited repertoire of VOC's may be present in horse faeces. This may be related to the evolutionary adaptation of intestinal microbiota to a herbivorous diet, to the limited diet (i.e. oats, dry forage and oil) of the horses in our study, and to the similarity in diet between all study horses.
- SIFT-MS is especially useful for looking at low molecular mass compounds; some of which could not be detected using the TD-GC- MS method used. SIFT-MS is better at obtaining quantitative data as the headspace is analysed directly. However, the greater sensitivity and identification ability of TD-GC-MS enables a much more effective qualitative investigation into the compounds present. The combination of the two techniques is an especially powerful strategy for investigating the faecal metabolome.
- Tb racehorse faeces is dominated by acids, alcohols and ketones, most likely derived from hindgut microbial digestion of carbohydrate. Sulphur-containing VOC's were detected less frequently and a limited number of aromatic compounds were present compared to human faeces.
- Multivariate analysis indicates that acetone was significantly increased in quantity and methanol significantly decreased in faeces after dietary supplementation with amylase-rich malt extract. These two compounds are worthy of further investigation as biomarkers for equine intestinal health.
- SIFT-MS gave more accurate results than TD-GC-MS as acetone was analysed directly; the TD sorbents used are better suited to higher molecular weight compounds.
- Our study demonstrates the utility and sensitivity of an analytical model for investigating the metabolic consequences of dietary supplementation in horses.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19211958.4A EP3639847B1 (en) | 2012-03-14 | 2013-03-13 | Horse feed supplement and its use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1204430.1A GB201204430D0 (en) | 2012-03-14 | 2012-03-14 | Dietary supplement and assay method |
| PCT/GB2013/050616 WO2013136069A2 (en) | 2012-03-14 | 2013-03-13 | Dietary supplement and assay method |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19211958.4A Division EP3639847B1 (en) | 2012-03-14 | 2013-03-13 | Horse feed supplement and its use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2825059A2 true EP2825059A2 (en) | 2015-01-21 |
Family
ID=46026478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19211958.4A Active EP3639847B1 (en) | 2012-03-14 | 2013-03-13 | Horse feed supplement and its use |
| EP13711456.7A Ceased EP2825059A2 (en) | 2012-03-14 | 2013-03-13 | Animal feed supplement and assay method |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19211958.4A Active EP3639847B1 (en) | 2012-03-14 | 2013-03-13 | Horse feed supplement and its use |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3639847B1 (en) |
| GB (1) | GB201204430D0 (en) |
| HK (1) | HK1204868A1 (en) |
| WO (1) | WO2013136069A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1023199B1 (en) * | 2015-09-21 | 2016-12-19 | Laboratoire D'analyses Medicales Roman Pais Sc | METHOD FOR ASSAYING VOLATILE SHORT CELL FATTY ACIDS |
| CN105796590A (en) * | 2016-03-21 | 2016-07-27 | 内蒙古莱德马业股份有限公司 | Electrolyte supplement needed for organism of physical exercise horse |
| GB201614415D0 (en) | 2016-08-24 | 2016-10-05 | Pepsis Ltd | Enzymes for the treatment of human enterometabolic dysfunction |
| GB201619789D0 (en) | 2016-11-23 | 2017-01-04 | Pepsis Ltd | Enzyme-rich malt extract formulations |
| EP3542639B1 (en) * | 2018-03-21 | 2023-06-14 | Viking Malt Oy | Ingredient for animal feed, feed and a method for feeding animals |
| GB201804837D0 (en) | 2018-03-26 | 2018-05-09 | Pepsis Ltd | Diagnostic methods in treatments in equine dieases |
| GB201907782D0 (en) * | 2019-05-31 | 2019-07-17 | Mars Inc | Method |
| GB2611095A (en) * | 2021-09-28 | 2023-03-29 | Ateria Health Australia Pty Ltd | A method for improving athletic energy and/or endurance in a human subject |
| GB2622839A (en) * | 2022-09-29 | 2024-04-03 | Ateria Health Australia Pty Ltd | A method for treating asthma |
| GB202218268D0 (en) * | 2022-12-05 | 2023-01-18 | Tharos Ltd | Dog food additive |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB190908932A (en) * | 1909-04-15 | 1909-09-30 | Leonard William Holmes | An Improved Dog Biscuit and Process of Manufacturing the same. |
| DD137944A1 (en) * | 1978-07-21 | 1979-10-03 | Franz Setzer | METHOD FOR PRODUCING COMBUSTION REPAIR MALT |
| DE3028361A1 (en) * | 1980-07-25 | 1982-03-11 | Brummer, Johann Georg, Dipl.-Brau-Ing., 8706 Höchberg | Highly diastatic kiln-dried malt, esp. wheat malt prepn. - by wet and dry steeping with germination-stimulator addn. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1019734A (en) * | 1908-12-26 | 1912-03-05 | F H Bennett Biscuit Company | Feeding-stuff. |
| GB191407742A (en) * | 1914-03-27 | 1915-07-15 | Antonius Adrianus Ter Haar | Improvements in Horse Food and Preparation of the same. |
| JPS6055098B2 (en) * | 1980-09-04 | 1985-12-03 | 天野製薬株式会社 | horse feed additives |
| US5662901A (en) * | 1987-07-21 | 1997-09-02 | Loveland Industries, Inc. | Enzymatic grain conditioner and methods of using it |
| US5314692A (en) * | 1987-08-24 | 1994-05-24 | Cultor Ltd. | Enzyme premix for feed and method |
| HU203956B (en) * | 1989-02-24 | 1991-11-28 | Sandor Kubo | Method for producing fodder rich in protein |
| US7005128B1 (en) * | 1993-12-17 | 2006-02-28 | Genencor International, Inc. | Enzyme feed additive and animal feed including it |
| ATE308896T1 (en) * | 1999-12-30 | 2005-11-15 | Kemin Ind Inc | METHOD FOR IMPROVING ENZYME ACTIVITY |
| WO2001059141A2 (en) * | 2000-02-10 | 2001-08-16 | Washington State University Research Foundation | Methods and compositions that utilize barley as a foodstuff for animals |
| US6750051B2 (en) * | 2001-04-10 | 2004-06-15 | University Of Kentucky Research Foundation | Compositions and methods for enhancing fiber digestion |
| WO2007045450A2 (en) * | 2005-10-21 | 2007-04-26 | Dsm Ip Assets B.V. | Use of fructanases in feed of hoofed animals to treat and prevent laminitis |
| US20090317515A1 (en) * | 2006-03-10 | 2009-12-24 | Basf Se | Solid enzyme formulations and process for their preparation |
| US20090252827A1 (en) * | 2008-02-20 | 2009-10-08 | Debra Baginski | Horse feed and methods of treating horses |
| US20120040047A1 (en) * | 2008-11-27 | 2012-02-16 | Frehner Marco | Use of natural substances as feed additives for animals of the genus equidae |
-
2012
- 2012-03-14 GB GBGB1204430.1A patent/GB201204430D0/en not_active Ceased
-
2013
- 2013-03-13 HK HK15105867.2A patent/HK1204868A1/en unknown
- 2013-03-13 EP EP19211958.4A patent/EP3639847B1/en active Active
- 2013-03-13 WO PCT/GB2013/050616 patent/WO2013136069A2/en not_active Ceased
- 2013-03-13 EP EP13711456.7A patent/EP2825059A2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB190908932A (en) * | 1909-04-15 | 1909-09-30 | Leonard William Holmes | An Improved Dog Biscuit and Process of Manufacturing the same. |
| DD137944A1 (en) * | 1978-07-21 | 1979-10-03 | Franz Setzer | METHOD FOR PRODUCING COMBUSTION REPAIR MALT |
| DE3028361A1 (en) * | 1980-07-25 | 1982-03-11 | Brummer, Johann Georg, Dipl.-Brau-Ing., 8706 Höchberg | Highly diastatic kiln-dried malt, esp. wheat malt prepn. - by wet and dry steeping with germination-stimulator addn. |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3639847A1 (en) | 2020-04-22 |
| WO2013136069A3 (en) | 2014-01-30 |
| GB201204430D0 (en) | 2012-04-25 |
| WO2013136069A2 (en) | 2013-09-19 |
| EP3639847B1 (en) | 2026-05-06 |
| HK1204868A1 (en) | 2015-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3639847B1 (en) | Horse feed supplement and its use | |
| Fan et al. | Proteomics integrated with metabolomics: analysis of the internal causes of nutrient changes in alfalfa at different growth stages | |
| Teoh et al. | Effects of hardwood biochar on methane production, fermentation characteristics, and the rumen microbiota using rumen simulation | |
| Agarwal et al. | In vitro methanogenesis, microbial profile and fermentation of green forages with buffalo rumen liquor as influenced by 2-bromoethanesulphonic acid | |
| Miron et al. | Composition and in vitro digestibility of monosaccharide constituents of selected byproduct feeds | |
| Navarro‐Villa et al. | In vitro rumen methane output of grasses and grass silages differing in fermentation characteristics using the gas‐production technique (GPT) | |
| Ribeiro et al. | Effect of ammonia fiber expansion-treated wheat straw and a recombinant fibrolytic enzyme on rumen microbiota and fermentation parameters, total tract digestibility, and performance of lambs | |
| Lengowski et al. | Effects of corn silage and grass silage in ruminant rations on diurnal changes of microbial populations in the rumen of dairy cows | |
| Zhao et al. | Effects of applying cellulase and starch on the fermentation characteristics and microbial communities of Napier grass (Pennisetum purpureum Schum.) silage | |
| Bertipaglia et al. | Effect of pelleting and pellet size of a concentrate for intensively reared beef cattle on in vitro fermentation by two different approaches | |
| Sheng et al. | Humic substances reduce ruminal methane production and increase the efficiency of microbial protein synthesis in vitro | |
| Liu et al. | Estimating ruminal crude protein degradation from beef cattle feedstuff | |
| Ju et al. | Effects of cellulase and Lactiplantibacillus plantarum on the fermentation quality, microbial diversity, gene function prediction, and in vitro rumen fermentation parameters of Caragana korshinskii silage | |
| Fitri et al. | Ensiling of total mixed ration containing persimmon peel: Evaluation of chemical composition and in vitro rumen fermentation profiles | |
| Li et al. | Effects of feeding different levels of dietary corn silage on growth performance, rumen fermentation and bacterial community of post-weaning dairy calves | |
| Velázquez et al. | Effect of partial replacement of steam rolled corn with Soybean hulls or Prickly pear cactus in the horse's diet in the presence of live Saccharomyces cerevisiae on in vitro fecal gas production | |
| CN102590013A (en) | Method for quickly detecting titer of non-starch polysaccharides for feeds | |
| De Smet et al. | Investigation of dry matter degradation and acidotic effect of some feedstuffs by means of in sacco and in vitro incubations | |
| Bugoni et al. | Dry malt extract from barley partially replacing ground corn in diets of dairy cows: Nutrient digestibility, ruminal fermentation, and milk composition | |
| HK40018778A (en) | Horse feed supplement and its use | |
| Purcell et al. | In vitro rumen methane output of perennial ryegrass varieties and perennial grass species harvested throughout the growing season | |
| Schiff et al. | In vitro gas production kinetics are influenced by grain processing, flake density, starch retrogradation, and Aspergillus oryzae fermentation extract containing α-amylase activity | |
| Edmunds et al. | In vitro analysis of the effect of supplementation with activated charcoal on the equine hindgut | |
| Guo et al. | Relationships between rumen methanogens and fungal communities and their response to changes in alfalfa forms and starch in sheep diets | |
| Xiong et al. | Effects of biochanin A on lactational performance, nitrogen metabolism, and blood metabolites in dairy cows |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20141007 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HUNT, JOHN Owner name: WARING, ROSEMARY HOPE |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1204868 Country of ref document: HK |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WARING, ROSEMARY Inventor name: HUNTER, JOHN |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: WARING, ROSEMARY HOPE Owner name: HUNTER, JOHN |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WARING, ROSEMARY HOPE Inventor name: HUNTER, JOHN |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PEPSIS LIMITED |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HUNTER, JOHN Inventor name: WARING, ROSEMARY |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20170704 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20200110 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1204868 Country of ref document: HK |